Neurology News

Known for his role as a pilot in “Star Wars,” actor Greg Grunberg has traded in his flight suit to travel cross country to bring awareness to epilepsy care, treatment and patient needs.

Biogen and Happify Health have announced a partnership to provide an artificial intelligence-powered digital solution for people with MS called Kopa, which will offer support for patients through education and engagement.

Long-term use of Xcopri was safe and reduced seizures by more than 90% in adults with uncontrolled focal seizures, according to results of an open-label extension study published in Neurology.

The FDA on June 23 announced a 5-year strategy for improving and extending the lives of people with rare neurodegenerative diseases by advancing development of safe and effective medical products and facilitating access to novel treatments.

Jazz Pharmaceuticals announced it has entered into a licensing agreement with Sumitomo Pharma Co. to develop and commercialize an oral treatment for narcolepsy, idiopathic hypersomnia and other sleep disorders.

AbbVie announced it has submitted a supplemental new drug application to the FDA for Qulipta, a preventive migraine treatment for adults.

DENVER — There may be a link between migraine and clinical endocannabinoid deficiency, a speaker said at the American Headache Society’s annual scientific meeting.

DENVER – Treatment with histone deacetylase 6 inhibitor restored neurol complexities and decreased migraine symptoms, Amynah Pradhan, PhD, said at the American Headache Society’s annual scientific meeting.

DENVER – More data are still needed on proper dosing of patients with eptinezumab for migraine prevention, Rami Apelian, MD, MPH, FAES, said at the American Headache Society’s annual scientific meeting.

Acadia Pharmaceuticals Inc. announced the outcome of the FDA advisory committee meeting on the use of pimavanserin for treating hallucinations and delusions associated with Alzheimer’s disease psychosis.